No complete picture on the types of tests being administered in India: The Indian Council of Medical Research (ICMR) does not maintain a database of the number of rapid antigen tests (RAT) and RT-PCR tests being administered for Covid-19 at the national level or across states, the medical research body has revealed. ICMR is the country's top body for overseeing biomedical research.
Delhi's caseload growing three times faster than the national rate: In the past week, Delhi has contributed more cases to India's caseload than any state, more than even Maharashtra. Over 46,000 cases were detected in Delhi compared to 36,000 cases in Maharashtra. Delhi has a growth rate of 1.6 per cent, which is more than three times the national rate. Delhi is also one of the few states that are witnessing a rise in active cases, with 42,000 active cases right now. The death count has also been going up sharply. Delhi has seen more deaths in the past few days than any state except Maharashtra. Read more here
Fact-checking the government's claims on Ashwagandha: On October 6, 2020, Union Health Minister Harsh Vardhan released an “AYUSH standard treatment protocol” for the clinical management of Covid-19. This included the herb Ashwagandha (Withania somnifera) for the prevention of Covid-19 among healthcare workers, those living in containment zones, and other high-risk groups. The herb was also recommended for the prevention of Covid-19 complications such as fatigue lung fibrosis (scarring of lung tissue). However, the use of the herb has been severely questioned. Read a detailed fact-check here on the efficacy of the herb and the truthfulness of the health ministry's claims.
Zinc deficiency: Deficiency in zinc has been associated with severe cases of Covid-19. This has led to renewed interest in the nutrient and has become an key component in the treatment plans for the Coronavirus disease. Read more here
To read the full story, Subscribe Now at just Rs 249 a month
Already a subscriber? Log in
Subscribe To BS Premium
₹249
Renews automatically
₹1699₹1999
Opt for auto renewal and save Rs. 300 Renews automatically
₹1999
What you get on BS Premium?
- Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
- Pick your 5 favourite companies, get a daily email with all news updates on them.
- Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
- Preferential invites to Business Standard events.
- Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
Need More Information - write to us at assist@bsmail.in